References
- World Health Organization National Action Plans and Monitoring and Evaluation, Surveillance, Prevention and Control. Global action plan on antimicrobial resistance. [accessed 2020 Feb 19]. https://www.who.int/publications/i/item/global-action-plan-on-antimicrobial-resistance.
- Vekemans J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, Fiore A, Tayler E, Klemm EJ, Laxminarayan R, Srikantiah P, Friede M, et al. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: a WHO action framework. Clin Infect Dis. 2021:ciab062. doi:10.1093/cid/ciab1062.
- European Centre for Disease Prevention and Control (ECDC)/European Medical Agency (EMEA) joint technical report: the bacterial challenge: time to react; 2009 [accessed 2021 Feb 19]. https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf.
- National Center for Environmental Health; National Center for Health Statistics; National Center for Infectious Diseases, CDC. Achievements in public health, 1900-1999: control of infectious diseases. MMWR Week. 1999;48(29):621–29.
- Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–76. doi:10.1080/10408398.2015.1077192.
- World Health Organization (WHO). Antimicrobial resistance. [accessed 2020 Feb 19]. https://www.who.int/health-topics/antimicrobial-resistance.
- Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–33. doi:10.1128/MMBR.00016-10.
- Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25–64. doi:10.4137/PMC.S14459.
- Dhingra S, Rahman NAA, Peile E, Rahman M, Sartelli M, Hassali MA, Islam T, Islam S, Haque M. Microbial resistance movements: an overview of global public health threats posed by antimicrobial resistance, and how best to counter. Front Public Health. 2020;8:535668.
- Organisation for Economic Co-operation and Development (OECD) Health Policy Studies. Stemming the superbug tide - just a few dollars more; 2018 [accessed 2020 Feb 19]. https://www.oecd.org/health/stemming-the-superbug-tide-9789264307599-en.htm.
- European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance in the EU/EEA (EARS-Net) annual epidemiological report for 2019; 2019 [accessed 2020 Feb 17]. https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2019.pdf.
- Organisation for Economic Co-operation and Development (OECD) and European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance tackling the burden in the European Union; 2019 [accessed 2020 Feb 19]. https://www.oecd.org/health/health-systems/AMR-Tackling-the-Burden-in-the-EU-OECD-ECDC-Briefing-Note-2019.pdf.
- European Centre for Disease Prevention and Control (ECDC). Mission report: ECDC country visit to Italy to discuss antimicrobial resistance issues; 2017 Jan 9-13 [accessed 2020 Feb 19]. https://www.ecdc.europa.eu/sites/default/files/documents/AMR-country-visit-Italy.pdf
- World Health Organization (WHO). Global action plan on antimicrobial resistance; 2015 [accessed 2021 Feb 19]. https://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/.
- World Health Organization (WHO). Antimicrobial resistance. The Seventy-second World Health Assembly; 2019 May 28 [accessed 2020 Feb 19. https://apps.who.int/gb/ebwha/pdf_files/WHA72/A72_R5-en.pdf.
- European Comission. EU action on antimicrobial resistance. [accessed 2021 Feb 26]. https://ec.europa.eu/health/antimicrobial-resistance/eu-action-on-antimicrobial-resistance_en.
- Commission notice — EU guidelines for the prudent use of antimicrobials in human health. C/2017/4326. [accessed 2021 Feb 26]. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52017XC0701%2801%29&qid=1614368348994.
- Ministero della Salute. antibiotico-resistenza [accessed 2021 Feb 26]. http://www.salute.gov.it/portale/antibioticoresistenza/homeAntibioticoResistenza.jsp.
- Piano Nazionale di Contrasto dell’Antimicrobico-Resistenza (PNCAR) 2017-2020. [accessed 2020 Feb 19]. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2660_allegato.pdf.
- Micoli F, Bagnoli F, Rappuoli R, Serruto D. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol. 2021;19:287–302. doi:10.1038/s41579-020-00506-3.
- Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020;90:188–96. doi:10.1016/j.ijid.2019.10.005.
- Lipsitch M, Siber GR. How can vaccines contribute to solving the antimicrobial resistance problem? mBio. 2016;7:3. doi:10.1128/mBio.00428-16.
- Bonanni P, Picazo JJ, Remy V. The intangible benefits of vaccination - what is the true economic value of vaccination? J Mark Access Health Policy. 2015;3:26964.
- Rodgers LR, Streeter AJ, Lin N, Hamilton W, Henley WE. Impact of influenza vaccination on amoxicillin prescriptions in older adults: a retrospective cohort study using primary care data. PLoS One. 2021;16(1):e0246156. doi:10.1371/journal.pone.0246156.
- Klugman KP, Black S. Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects. Proc Natl Acad Sci U S A. 2018;115(51):12896–901. doi:10.1073/pnas.1721095115.
- Doherty TM, Hausdorff WP, Kristinsson KG. Effect of vaccination on the use of antimicrobial agents: a systematic literature review. Ann Med. 2020;52(6):283–99. doi:10.1080/07853890.2020.1782460.
- Buckley BS, Henschke N, Bergman H, Skidmore B, Klemm EJ, Villanueva G, Garritty C, Paul M. Impact of vaccination on antibiotic usage: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(10):1213–25. doi:10.1016/j.cmi.2019.06.030.
- Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Churchill Livingstone; 2000. p. 155–156.
- Gazzetta Ufficiale Della Repubblica Italiana. Piano Nazionale Prevenzione Vaccinale (PNPV) 2017-2019; 2017 [accessed 2020 Feb 19]. http://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=18/02/2017&redaz=17A01195&artp=1&art=1&subart=1&subart1=10&vers=1&prog=001.
- European Centre for Disease Prevention and Control (ECDC). Survey of healthcare workers’ knowledge, attitudes and behaviours on antibiotics, antibiotic use and antibiotic resistance in the EU/EEA; 2019 [accessed 2020 Feb 23]. https://www.ecdc.europa.eu/sites/default/files/documents/survey-of-healthcare-workers-knowledge-attitudes-behaviours-on-antibiotics.pdf.
- Krockow EM, Colman AM, Chattoe-Brown E, Jenkins DR, Perera N, Mehtar S, Tarrant C. Balancing the risks to individual and society: a systematic review and synthesis of qualitative research on antibiotic prescribing behaviour in hospitals. J Hosp Infect. 2019;101(4):428–39. doi:10.1016/j.jhin.2018.08.007.
- Salsgiver E, Bernstein D, Simon MS, Eiras DP, Greendyke W, Kubin CJ, Mehta M, Nelson B, Loo A, Ramos LG, et al. Knowledge, attitudes, and practices regarding antimicrobial use and stewardship among prescribers at acute-care hospitals. Infect Control Hosp Epidemiol. 2018;39(3):316–22. doi:10.1017/ice.2017.317.
- Labricciosa FM, Sartelli M, Correia S, Abbo LM, Severo M, Ansaloni L, Coccolini F, Alves C, Melo RB, Baiocchi GL, et al. Emergency surgeons’ perceptions and attitudes towards antibiotic prescribing and resistance: a worldwide cross-sectional survey. World J Emerg Surg. 2018;13(1):27. doi:10.1186/s13017-018-0190-5.
- Malarski M, Hasso-Agopsowicz M, Soble A, Mok W, Mathewson S, Vekemans J. Vaccine impact on antimicrobial resistance to inform Gavi, the vaccine alliance’s 2018 vaccine investment strategy: report from an expert survey. F1000Res. 2019;8:1685. doi:10.12688/f1000research.20100.1.
- van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37–62. doi:10.1016/j.cmi.2016.01.007.
- Igidbashian S, Bertizzolo L, Tognetto A, Azzari C, Bonanni P, Castiglia P, Conversano M, Esposito S, Gabutti G, Icardi G, et al. Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy. J Prev Med Hyg. 2020;61(2). E152–E161.
- Surveillance on antimicrobial resistance, 2018. European Center for Disease Control and Prevention (ECDC). [accessed 2021 Apr 14]. https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2018.pdf.
- Siani A. Measles outbreaks in Italy: a paradigm of the re-emergence of vaccine-preventable diseases in developed countries. Prev Med. 2019;121:99–104. doi:10.1016/j.ypmed.2019.02.011.
- Morbillo e Rosolia News, Rapporto n.37, Gennaio 2018. Istituto Superiore di Sanità. [accessed 2021 Apr 14]. https://www.epicentro.iss.it/morbillo/bollettino/RM_News_2018_37%20def.pdf.
- Bechini A, Boccalini S, Baldo V, Cocchio S, Castiglia P, Gallo T, Giuffrida S, Locuratolo F, Tafuri S, Martinelli D, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71. doi:10.4161/hv.34311.
- Bernal JL, Hobbelen P, Amirthalingam G. Burden of varicella complications in secondary care, England, 2004 to 2017. Euro Surveill. 2019;24:42. doi:10.2807/1560-7917.ES.2019.24.42.1900233.
- Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? a systematic literature review. Expert Rev Vaccines. 2019;18(5):439–55. doi:10.1080/14760584.2019.1588727.
- Blasi F, Bonanni P, Braido F, Gabutti G, Marchetti F, Centanni S. The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. Hum Vaccin Immunother. 2020;16(2):340–48. doi:10.1080/21645515.2019.1652517.
- European Centre of Disease Control and Prevention (ECDC). Surveillance atlas of infectious diseases - Pertussis Italy 2018. [accessed 2021 Apr 15]. https://atlas.ecdc.europa.eu/public/index.aspx.
- European Centre for Disease Prevention and Control (ECDC). Pertussis annual epidemiological report for 2018. [accessed 2021 May 10]. https://www.ecdc.europa.eu/en/publications-data/pertussis-annual-epidemiological-report-2018.
- Statistiche Demografiche - Italia. Popolazione per età, sesso e stato civile 2019. [accessed 2021 May 10]. https://www.tuttitalia.it/statistiche/popolazione-eta-sesso-stato-civile-2019/.
- Chen CC, Balderston McGuiness C, Krishnarajah G, Blanchette CM, Wang Y, Sun K, Buck PO. Estimated incidence of pertussis in people aged <50 years in the United States. Hum Vaccin Immunother. 2016;12(10):2536–45.
- L’uso degli antibiotici in Italia. Rapporto nazionale 2018. Agenzia Italiana del Farmaco. [accessed 2021 Apr 14]. http://www.salute.gov.it/imgs/C_17_pubblicazioni_2894_allegato.pdf.
- Hasso-Agopsowicz M, Prudden H, Vekemans J, World Health Organization. Value attribution framework for vaccines against antimicrobial resistance; 2019 [accessed 2021 Feb 26]. https://www.who.int/immunization/research/meetings_workshops/5_Hasso_Prudden_AMR_PDVAC_2019.pdf?ua=1.
- Rossato L, Negrao FJ, Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance? Am J Infect Control. 2020;48(9):1129–30. doi:10.1016/j.ajic.2020.06.192.
- Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409–10. doi:10.1038/s41579-020-0395-y.
- Lucien MAB, Canarie MF, Kilgore PE, Jean-Denis G, Fénélon N, Pierre M, Cerpa M, Joseph GA, Maki G, Zervos MJ, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int J Infect Dis. 2021;104:250–54. doi:10.1016/j.ijid.2020.12.087.
- Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9–11. doi:10.1016/j.cmi.2020.09.025.
- Pelfrene E, Botgros R, Cavaleri M. Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight? Antimicrob Resist Infect Control. 2021;10(1):21. doi:10.1186/s13756-021-00893-z.
- Zhu N, Aylin P, Rawson T, Gilchrist M, Majeed A, Holmes A. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect. 2021;27(5):762–68. doi:10.1016/j.cmi.2021.02.007.
- Monnet DL, Harbarth S. Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Euro Surveill. 2020;25:45. doi:10.2807/1560-7917.ES.2020.25.45.2001886.